For 14 years, Jesse’s mind spiraled. So did his weight. The medications he took for schizophrenia drove his weight up until ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

The "takings clause" in the Fifth Amendment to the U.S. Constitution might keep the federal government from creating ...

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

Danish drugmaker Novo Nordisk has made billions of dollars from its GLP-1s, including pills and injectable drugs like Ozempic ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half. What doesn’t it ...

Consumer groups and labor unions urged the U.S. FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, warning it ...

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...